I am actually hoping for them to sell the Dx divis
Post# of 30028
It would grantee funding to move ESS, Elto, and Manf, pad the books to limit dilution and almost grantee our up list to the nasdaq.
I know many believe that Lympro or MS precise could bring in greater Revenue long term but as a small cash strapped company, we may have to consider that option.
WD